PureTech Health plc
PRTC · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $2 | $4 | $0 | $0 |
| % Growth | -54% | 1,298.3% | 61.3% | – |
| Cost of Goods Sold | $25 | -$39 | $39 | $2 |
| Gross Profit | -$23 | $43 | -$39 | -$2 |
| % Margin | -1,245.2% | 1,066.7% | -13,416.7% | -940% |
| R&D Expenses | $25 | $15 | $39 | $43 |
| G&A Expenses | $25 | -$0 | $28 | $14 |
| SG&A Expenses | $25 | -$0 | $28 | $25 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $11 |
| Other Operating Expenses | -$25 | $98 | -$39 | $0 |
| Operating Expenses | $25 | $113 | $28 | $68 |
| Operating Income | -$48 | -$70 | -$66 | -$69 |
| % Margin | -2,589.5% | -1,730.7% | -23,054.9% | -38,910.1% |
| Other Income/Exp. Net | $4 | $149 | $11 | $47 |
| Pre-Tax Income | -$44 | $79 | -$55 | -$22 |
| Tax Expense | $1 | $2 | -$6 | $19 |
| Net Income | -$45 | $95 | -$42 | -$40 |
| % Margin | -2,409.8% | 2,366.1% | -14,504.5% | -22,606.7% |
| EPS | -1.9 | 3.5 | -1.5 | -0.74 |
| % Growth | -154.3% | 333.3% | -102.7% | – |
| EPS Diluted | -1.9 | 3.5 | -1.5 | -0.75 |
| Weighted Avg Shares Out | 23 | 27 | 27 | 27 |
| Weighted Avg Shares Out Dil | 24 | 27 | 27 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $11 | $12 | $8 |
| Interest Expense | $1 | -$1 | $11 | $8 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$46 | $102 | -$65 | -$11 |
| % Margin | -2,498.1% | 2,532.1% | -22,425% | -6,253.4% |